[1] |
中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒,淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J]. 中华皮肤科杂志, 2020,53(3):12. doi: 10.35541/cjd.20190808.
|
[2] |
Stolle AS, Meader BT, Toska J, et al. Endogenous membrane stress induces T6SS activity in Pseudomonas aeruginosa[J]. Proc Natl Acad Sci U S A, 2021,118(1):e2018365118. doi: 10.1073/pnas.2018365118.
|
[3] |
Nguyen Y, Kim C, Kim Y, et al. The Orientia tsutsugamushi ScaB autotransporter protein is required for adhesion and invasion of mammalian cells[J]. Front Microbiol, 2021,12:626298. doi: 10.3389/fmicb.2021.626298.
|
[4] |
Hörnström D, Larsson G, van Maris A, et al. Molecular optimization of autotransporter⁃based tyrosinase surface display[J]. Biochim Biophys Acta Biomembr, 2019,1861(2):486⁃494. doi: 10.1016/j.bbamem.2018.11.012.
|
[5] |
Huang J, Zhang Q, Chen J, et al. Neisseria gonorrhoeae NGO2105 is an autotransporter protein involved in adhesion to human cervical epithelial cells and in vivo colonization[J]. Front Microbiol, 2020,11:1395. doi: 10.3389/fmicb.2020.01395.
|
[6] |
王光丽, 范婵, 王辉, 等. 霍乱弧菌溶血素HlyA的原核表达,纯化及多克隆抗体制备与鉴定[J]. 生物技术通报, 2022,38(7): 269⁃277. doi: 10.13560/j.cnki.biotech.bull.1985.2021⁃1299.
|
[7] |
Ruiz⁃Perez F, Nataro JP. Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence[J]. Cell Mol Life Sci, 2014,71(5):745⁃770. doi: 10.1007/s00018⁃013⁃1355⁃8.
|
[8] |
Pohlner J, Halter R, Beyreuther K, et al. Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease[J]. Nature, 1987,325(6103):458⁃462. doi: 10.1038/325458a0.
|
[9] |
Khairalla AS, Omer SA, Mahdavi J, et al. Nuclear trafficking, histone cleavage and induction of apoptosis by the meningococcal App and MspA autotransporters[J]. Cell Microbiol, 2015,17(7):1008⁃1020. doi: 10.1111/cmi.12417.
|
[10] |
Semchenko EA, Day CJ, Seib KL. MetQ of Neisseria gonorrhoeae is a surface⁃expressed antigen that elicits bactericidal and functional blocking antibodies[J]. Infect Immun, 2017,85(2): e00898⁃16. doi: 10.1128/IAI.00898⁃16.
|
[11] |
Shetye GS, Franzblau SG, Cho S. New tuberculosis drug targets, their inhibitors, and potential therapeutic impact[J]. Transl Res, 2020,220:68⁃97. doi: 10.1016/j.trsl.2020.03.007.
|
[12] |
Xu H, Cai L, Hufnagel S, et al. Intranasal vaccine: factors to consider in research and development[J]. Int J Pharm, 2021, 609: 121180. doi: 10.3389/fmicb.2021.785649
|
[13] |
Bahamondez⁃Canas TF, Cui Z. Intranasal immunization with dry powder vaccines[J]. Eur J Pharm Biopharm, 2018,122:167⁃175. doi: 10.1016/j.ejpb.2017.11.001.
|
[14] |
Hickey AJ, Garmise RJ. Dry powder nasal vaccines as an alternative to needle⁃based delivery[J]. Crit Rev Ther Drug Carrier Syst, 2009,26(1):1⁃27. doi: 10.1615/critrevtherdrugcarriersyst.v26.i1.10.
|
[15] |
Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis[J]. Nat Rev Microbiol, 2018,16(4):226⁃240. doi: 10.1038/nrmicro.2017.169.
|